Related Experiment Video
Updated: Jul 5, 2026

Analysis of Group IV Viral SSHHPS Using In Vitro and In Silico Methods
Published on: December 21, 2019
Primate lentivirus capsid sensitivity to TRIM5 proteins.
Zerina Kratovac1, Cesar A Virgen, Frederick Bibollet-Ruche
1Aaron Diamond AIDS Research Center and the Rockefeller University, New York, NY 10016, USA.
Mammalian cells possess TRIM5 proteins that restrict lentiviral infection by targeting viral capsids. This study reveals TRIM5
Area of Science:
- Virology
- Immunology
- Genetics
Background:
- Mammalian cells have evolved antiviral factors, including TRIM5, which inhibit lentiviral replication by targeting viral capsid proteins.
- TRIM5 is a key component of the innate immune system, exerting selective pressure on lentiviruses.
Purpose of the Study:
- To investigate the specificity of TRIM5alpha restriction against diverse primate lentiviral capsids.
- To identify novel primate lentiviral capsids that are recognized by TRIMCyp proteins.
Main Methods:
- Substitution of human immunodeficiency virus type 1 capsid with divergent primate lentiviral capsids.
- Analysis of TRIM5alpha restriction specificities across different primate species.
- Identification of TRIMCyp-targeted capsids.
Main Results:
- Primate lentiviral capsids were generally not susceptible to restriction by TRIM5 proteins from higher primates.
- TRIM5alpha proteins from various primates displayed distinct specificities for primate lentiviral capsids.
- Novel primate lentiviral capsids susceptible to TRIMCyp-mediated restriction were identified.
Conclusions:
- TRIM5alpha exhibits variable restriction patterns against primate lentiviruses, indicating co-evolutionary dynamics.
- TRIMCyp represents a distinct restriction factor targeting specific primate lentiviral capsids.
- Understanding these interactions is crucial for lentiviral vector development and antiviral strategies.
More Related Videos
08:33Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
13:47Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models
Published on: March 29, 2019
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Leaky Scanning